Inhibition of ERK1/2 by silymarin in mouse mesangial cells

Cha Kyung Youn1, Sung Il Cho2, Min Young Lee3

  • 1Department of Premedical Sciences, Chosun University College of Medicine, Gwangju 61452, Korea.

Insights

Pro-inflammatory cytokines synergistically increase nitric oxide (NO) in kidney cells. Silymarin, a milk thistle compound, effectively reduces this NO production by inhibiting inducible nitric oxide synthase (iNOS).

Area of Science:

  • Nephrology
  • Immunology
  • Pharmacology

Background:

  • Pro-inflammatory cytokines, including tumor necrosis factor-alpha (TNF-α), interferon-gamma (IFN-γ), and interleukin-1 beta (IL-1β), are implicated in inflammatory glomerular injury.
  • Nitric oxide (NO) production by mesangial cells plays a critical role in these inflammatory processes.

Purpose of the Study:

  • To investigate the synergistic effect of TNF-α, IFN-γ, and IL-1β on nitric oxide (NO) production in mouse mesangial cells.
  • To evaluate the potential of silymarin, a flavonoid from milk thistle (Silybum marianum), as an inhibitor of cytokine-induced NO production and its underlying mechanisms.

Main Methods:

  • Mouse mesangial cells were treated with combinations of TNF-α, IFN-γ, and IL-1β at varying concentrations.
  • Nitric oxide production was measured.
  • Silymarin's effects on NO production, inducible nitric oxide synthase (iNOS) expression (via Western blot and RT-PCR), and extracellular signal-regulated kinase 1 and 2 (ERK1/2) phosphorylation were assessed.

Main Results:

  • Low-dose co-treatment with TNF-α, IFN-γ, and IL-1β synergistically induced significant NO production, while individual cytokines did not at higher doses.
  • Silymarin effectively attenuated the synergistic NO production induced by the cytokine mixture.
  • Silymarin demonstrated a dose-dependent inhibition of iNOS expression and reduced ERK1/2 phosphorylation.

Conclusions:

  • Pro-inflammatory cytokines synergistically stimulate NO production in mouse mesangial cells, contributing to inflammatory kidney injury.
  • Silymarin exhibits anti-inflammatory properties by inhibiting NO production, likely through the downregulation of iNOS expression and modulation of signaling pathways like ERK1/2.
  • Silymarin shows promise as a therapeutic agent for inflammatory kidney diseases.

Related Concept Videos